Co-Founder Michael Klichinsky, PharmD Presents at Society for Immunotherapy for Cancer Conference

Co-Founder Michael Klichinsky, PharmD presented a poster titled “Chimeric antigen receptor macrophages (CARMA) for adoptive cellular immunotherapy of solid tumors” at the Society for Immunotherapy for Cancer (SITC) Conference, November 9-13, 2016 in National Harbor, MD. Dr. Klichinsky received a Young Investigator Award from the Society “based on the quality of … research and potential to advance the field.”

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s